The role of the glycans of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) in the intracellular events of Env precursor (gpl60) biosynthesis has been examined by the use of a mutant gpl60 in which the cluster of conserved glycosylation sites within the gp41 domain has been mutated. Expression of the wild-type and mutant forms of gpl60 in BHK-21 cells using recombinant vaccinia viruses has shown that the kinetics of the events occurring in the endoplasmic reticulum (ER) were normal: both Env proteins had similar kinetics of disulphide bond formation, as determined by the acquisition of CD4-binding capability, and both had similar kinetics of oligomer formation. However, in contrast to the parental molecule, mutated gpl60 displayed relatively slow transport from the cis to the medial Golgi where it was retained in the oligomeric state. Transport to the trans Golgi was impaired, as determined by the sensitivity of gpl60 to glycosidases. Cleavage of mutated gpl60 at the gpl20/gp41 junction was substantially reduced but this was apparently not due to the involvement of the gp41 glycosylation in the cleavage reaction by furin inasmuch as, in the baculovirus system, mutated gpl60 could be cleaved when recombinant furin was co-expressed. The reduced cleavage in mammalian cells may thus reflect the impaired routing of mutated Env to the compartment where cleavage occurs. The glycan component of gp41 is, therefore, important for the efficient intracellular transport and processing of gpl60, gpl60 lacking gp41 carbohydrates is an additional example, among few others, of a protein lacking glycans that is arrested in the Golgi rather than the ER following its biosynthesis.
The human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) is heavily glycosylated, with glycans representing 50 % of the molecular mass of the mature Env precursor, gpl60. We and others have suggested that the primary role of N-linked glycans is to induce during biosynthesis (but not to maintain in mature glycoproteins) the conformation necessary for Env functions (Fenouillet & Jones, 1994) . Indeed, although enzymatic deglycosylation of gpl20 and gp41 only slightly alters their bioactivity, abnormal glycosylation during biosynthesis results in strong inhibition of gp 160 cleavage and lack of Env-mediated cell and virus membrane fusion (Fenouillet & Jones, 1994; Moore et al., 1993) .
Glycosylation might influence glycoprotein folding through chaperonins with lectin-like properties, as was recently described (Hammond et al., 1994) . However, * Author for correspondence (mail should be sent to the Marseille address). Fax +33 91 65 75 95. because glycosylation is also a signal that influences the intracellular routing of viral glycoproteins (Doms et al., 1993; Machamer et al., 1985) and because the processing and folding of gpl60 is dependent on its intracellular transport (Earl et al., 1991 ; Moore et al., 1993) , it is also possible that several abnormal phenotypes could derive from a key change in the molecule's secretion pathway. Thus, the lack of some glycans on gpl60, or a block in one of the glycosytation steps during biosynthesis, could result in impaired intracellular transport of the molecule and in abnormal biological activity, as investigated with regard to HIV glycoproteins in some previous studies (Pal et al., 1989; Bolmstedt et al., 1991; Dedera et al., 1992; Dash et al., 1994) .
This possibility was also considered in a previous paper (Fenouillet et al., 1993) in which we reported a mutant of gp 160 lacking glycans in the transmembrane domain of HIV-1 gp41 that is severely impaired in cleavage, cell surface Env expression and gp41 function [i.e. fusion of the virus and host cell membranes after gpl20-mediated binding of the virus to cell surface CD4 (Moore et al., 1993) ]. These pleiotropic consequences were not surprising; the ectodomain of gp41 presents a conserved cluster of glycosylation sites on a 30 amino acid (aa) peptide spanning residues 615 to 645 (Gallaher et al., 1989; Desrosiers et al., 1987) and this cluster is located in a region close to the domain involved in the non-covalent binding of gp41 to gp 120 and, according to current models (Gallaher et al., 1989) , to the gpl60 cleavage site, to the fusion peptide and to the region involved in gpl60 oligomerization.
Moreover, our previous results were confirmed by a recent study indicating that mutation of Asn-642 prevented gpl60 cleavage and cell surface expression (Dash et al., 1994) . In contrast, it was observed that mutation of a single glycosylation site in gp41 has only marginal effects on Env intracellular processing and biological activity (Dedera et al., 1992) . This discrepancy can be explained in the light of the literature, which suggests that in contrast to multiple glycosylation site mutations, single glycosylation site removal usually does not affect viral glycoprotein biological activity. Alternatively, the difference in the results obtained might be that the system used by Dash et al. (a non-replicative HIV system; negating the possibility that compensatory mutations may have occurred) had advantages over that used by Dedera et al.
Biochemical studies of Env intracellular transport investigating the functional basis of the phenotype induced by the lack of glycosylation on the gp41 molecule were not performed in our previous study, nor in the study of Dash et al. (1994) . Here, we investigate the stage at which the envelope bearing non-glycosylated gp41 is arrested in its biosynthetic pathway. The normal HIV Env pathway requires successive events such as glycosylation of the precursor gpl60, folding, oligomerization and cleavage into the active domains of transmembrane gp41 and surface gpl20 in the Golgi (Earl et al. 1991 ; Moore et al., 1993) . Each of these steps has been studied here.
The binding of the Env to CD4 is a complex process involving different regions of the molecule and requires correctly formed disulphide bonds (Moore et al., 1993) . The monitoring of the ability of gpl60 to bind CD4, therefore, is one method for following the early folding events that are known to occur during gp 160 biosynthesis in the ER (Earl et al., 1991) .
Recombinant vaccinia viruses (rVV) expressing either the HIV-1Bru wild-type Env gene [clone VVTG9-1 (VV9-1)] (Ki6ny et al., 1988); a gift from M.-P. Ki6ny (Transg~ne SA, Strasbourg, France) or a gpl60 gene with Asn to Gin changes at each of the three conserved gp41 glycosylation sites at positions 621, 630 and 642, which results in no glycosylation of the gp41 domain as described in Fenouillet et aL (1993) (1993) for 20 min. An incubation in chase medium of 100 min was performed. Cells and supernatants were separated by centrifugation and lysed in 25mM-Tris HC1, 150 m~-NaC1 pH 7.4 supplemented with 1% NP40 and 0.2% sodium deoxycholate. Recombinant antigens present in the lysates were incubated with (i) Ab 9305 (an anti-V3 monoclonal antibody from DuPont de Nemours, Dreieich, Germany) (2 pg/ml) or (ii) sCD4 (2 gg/ml) and the complexes were then immunoprecipitated by (i) Protein A-Sepharose (Pharmacia) or (ii) OKT4 (an anti-CD4 antibody from Becton Dickinson) (10 gg/ml) and Protein A-Sepharose, respectively. Radiolabelled proteins were eluted using 10 % SDS, and analysed by 10% SDS-PAGE and autofluorography.
After a 20 min pulse, the amount of radiolabelled VV0 and VV9-1 gpl60 immunoprecipitated using the antigpl60 antibody or co-precipitated with CD4 by OKT4 was similar, suggesting that the gpl60 expressed by both VV0 and VV9-1 acquired the ability to bind CD4 within 20 min of biosynthesis (Fig. 1) . The slight difference in molecular mass noted between VV0 and VV9-1 gpl60 is probably due to a difference in their glycosylation pattern (see below) and to the absence of glycans on VV0 gp41. The similar ability of the pool of synthesized VV0 and VV9-1 gp 160 to bind CD4 was also confirmed by a CD4 ELISA which specifically captured gp 160 (data not shown). After a 100 min incubation in chase medium, cleavage of the gp 160 encoded by VV9-1 was apparent and both the parental gpl60 and cleaved gpl20 still bound CD4. By contrast, VV0 gpl60 remained largely uncleaved after this time but retained the ability to bind CD4 and was not substantially degraded. Thus, the kinetics of synthesis, as shown by the rate of incorporation of [35S]methionine, and the early folding events during transit in the ER appear normal for both VV0-and VV9-1-encoded gpl60.
Oligomerization of gpl60 also occurs in the ER following the acquisition of the ability to bind CD4 (Earl et al., 1991) . Oligomerization may be a key event for the correct intracellular routing and the complete processing and folding of viral Env (Doms et al., 1993; Hurtley & Helenius, 1989) . We studied the assembly of VV9-1-and VV0-encoded gp 160 into multimer structures in order to study the influence of gp41 glycosylation on the oligomerization process.
BHK-21 cells were labelled 15 h p.i. as described above and a chase of 30 or 180 min was performed. Cells were lysed in 25 mM-Tris-HC1, 150 mM-NaC1, pH 7.4 supplemented with 40 mM-octylglucoside (Sigma) and [z~S]methionine for 20 min and incubated in chase medium for an additional I00 rain (120 min). The gpl60 and gpl20 present in the lysate were precipitated using anti-V3 MAb (Ab) or coprecipitated with CD4 by OKT4 (T4) and analysed on a 10% SDS-polyacrylamide gel. membrane-free lysates were fractionated by velocity gradient centrifugation analysis on a 5-20% sucrose gradient in Tris-HC1 buffer pH7-4, 40mM-octylglucoside. Ultracentrifugation (SW40 rotor, 40000 r.p.m.) was performed for 24 h at 4 °C and 12 fractions (800 gl each) were then collected from the bottom of the gradient. Immunoprecipitation was performed using serum from an AIDS patient (1:50 dilution) as described in Fenouillet et al. (1993) and the immunoprecipitated antigens were analysed by SDS-PAGE followed by autoradiography.
After a 30 rain incubation in chase medium, both W9-1 and VV0 gpl60 species were detected at a similar level in multimeric form (Fig. 2) . Small amounts of cleaved gpl20 subunit were present in fractions corresponding either to VV9-1 gp160 monomers or to both VV0 gp 160 monomers and multimers. Expression of the gpl60 encoded by VV9-1 led to the detection of an additional 140-150 kDa band in the fractions where processed gpl20 is present ( Fig. 2 ; fractions 6, 7 and 8). It is likely that this species corresponds to parental gp 160 with fully processed complex glycans present in the Golgi. After a 180 min chase, limited amounts of VV9-1 multimeric gp160 were still observed although the majority of the label was associated with cleaved gp120 monomeric forms. In contrast, in the VV0 infection, the majority of the label was retained in high molecular mass structures and very little labelled gpl20 was present. The glycoproteins involved in these oligomers were shown not to be disulphide cross-linked as they migrated with the same mobility as gpl60 after SDS treatment in the absence of 2-mercaptoethanol. Despite the suggested role of the domain encoding the mutated glycosylation sites in the oligomerization process (Gallaher et al., 1989) , oligomer formation was not modified by the lack of gp41 glycans.
The study of the kinetics of transit from the ER to the Golgi was based on the sensitivity of glycoproteins to Endoglycosidase H (Endo H) or sialidase. The glycosylation pattern of a glycoprotein reflects the compartment through which the molecule has passed: to be fully Endo H-sensitive, a glycoprotein should present glycans composed only of high-mannose species, a structure synthesized in the ER and cis Golgi compartment (Kornfeld & Kornfeld, 1985; Tarentino et al., 1989) . A partially Endo H-resistant glycoprotein indicates that it displays complex Endo H-resistant glycans, typical of those synthesized in the medial/trans Golgi compartment. Finally, sialidase sensitivity indicates that the glycoprotein has been sialylated and has reached the trans Golgi (Fig. 3) .
BHK-21 ceils were labelled as described above and, after a chase of 30 or 180 min, lysed in 25 mM-Tris-HC1, 150 mM-NaC1 pH 7.4 supplemented with 1% Triton X- 100 and 0.25 % SDS. Antigens were immunoprecipitated and treated with Endo H (200 mU) and sialidase (100 mU) when necessary, followed by 10 % SDS-PAGE and autofluorography. After a 20 min pulse, both VV9-1-and VV0-encoded gpl60 were essentially fully Endo H-sensitive (Fig. 3) indicating they are in the ER and cis Golgi compartment (Kornfeld & Kornfeld, 1985; Tarentino et al., 1989) . After a 30rain chase, VV9-1 gpl60 was essentially resistant to Endo H whereas some VV0 gpl60 was still fully Endo H-sensitive. Thus, some of these species were still present in the rough ER/cis Golgi at this time. After a 180 min chase, most label was associated with VV9-1 cleaved gpl20 whereas cleavage of VV0 gp160 was only detectable on a very long-exposure autoradiogram (data not shown). Moreover, some VV0 gpl60 remained Endo H-sensitive and was thus still present in the ER/cis Golgi. In addition, and in contrast to what was observed with respect to VV9-1 gpl20, the Endo H-resistant species of VV0 gpl60 were sialidase resistant indicating an impaired transport to the trans Golgi (Fig. 3) . The fact that glycosidase-treated VV9-1 gpl60 is not detectable after Endo H treatment is consistent with the previous observations of Earl et al. (1991) .
Maturation of gpl60 to gpl20 and gp41 is thought to occur in the Golgi during glycoprotein transport by an enzyme with furin-like activity. The failure of VV0 gp 160 to be efficiently cleaved in BHK-21 cells could therefore be a consequence of the reduced ability of the molecule to complete the secretion pathway. However, it is also possible that the lack of gp41 glycosylation on VV0 gpl60 causes either a conformational change that leads to the inaccessibility of the cleavage site to furin or impairs the cleavage reaction for another reason.
To test this hypothesis, VV0 was removed from the intermediate transfer vector, cloned into the transfer vector pAcC129-1 and a baculovirus expressing the mutant Env was made by standard methodology (Kitts et al., 1991 : Livingstone & Jones, 1989 . Spodoptera frugiperda cells were co-infected at an m.o.i, of 5 with recombinant baculoviruses expressing either the wildtype gpl60 (VV9-1) or the mutant gpl60 (VV0) and with a recombinant virus expressing furin (furin) as in Morikawa et al. (1993) . Only gpl60 that had passed through the Golgi and had been released from cells, was analysed by Western blot 2 days p.i. In this system, both (VV0) and (VV9-1) gp 160 were equally secreted into the cell supernatant (Fig. 4) , indicating that the secretion pathway of VV0 gpl60 through the Golgi, where furin and substrate co-localize when furin is co-expressed (Morikawa et al., 1993) , is similar to that of VV9-1 gpl60. Analysis of the gpl60 present in the supernatant of cells co-infected with (VV9-1) and (furin) or (VV0) and (furin) showed that in this system, furin cleavage of (VV0) gpl60 was similar to that of the (VV9-1) gpl60 (Fig. 4) , as shown by the disappearance of the 160 kDa species when furin was co-expressed. Thus, the glycans present on gp41 are not directly involved in the cleavage reaction of Env by furin.
In conclusion, although the events that occur during the first 20 rain of the biosynthetic pathway in the ER are apparently not affected by lack of gp41 glycans, subsequent steps in the secretion pathway [e.g. the cleavage process and the acquisition of partial resistance to Endo H deglycosylation that appear concomitantly within a 1 h period after translation as gpl60 progresses from the ER to the medial Golgi (Earl et al., 1991) ] were modified by the mutations encoded by VV0. It would appear therefore, that transport between these compartments is dependent on the normal glycosylation of gp41. The routing of uncleaved VV0 gpl60 from the medial Golgi to the trans Golgi is also profoundly impaired. Surprisingly, as determined by ELISA, the amount of both VV0-and VV9-1-encoded gp 160 present in cells 2 days p.i. was in the same range (data not shown), suggesting that there was no preferential sequestration or degradation of the uncleaved gpl60 expressed by VV0. Taken together, these data suggest that blockage of VV0 gpl60 secretion occurs at a post-ER stage. It is of note that there are only few examples of proteins presenting abnormal intracellular routing that are arrested in the Golgi rather than the ER during their biosynthesis (Guan & Rose, 1984) ; VV0 gpl60 appears to be an additional example.
In contrast, the glycosylation of the small subset of cleaved, bioactive and secreted VV0 gpl20 in the cell supernatant (Fenouillet et al., 1993) and that of its VV9-1 counterpart was similar as determined by their sensitivity to Endo H and sialidase (data not shown). This suggests that the intracellular routing of a small proportion of secreted VV0 gpl20 was the same as that of VV9-1 gpl20 and that the block to secretion is not complete. As suggested by Willey et al., a proportion of such gpl20 species may be produced in association with the ER and may result from aberrant translation initiation or premature termination in a region of Env near the cleavage site (Willey et al., 1991) . It might also be the result of a second pathway for the secretion of HIV gpl20 as reported recently for SIV gpl20 (Spies & Compans, 1993) . Finally, it cannot be excluded that the presence of gp41 glycans may modulate the conformation of the protein that is required for correct transport and processing. In this case, a small proportion of molecules may achieve the folding required for subsequent transport despite the lack of carbohydrate on gp41. This is in line with the presence of a limited amount of VV0 gp41 and gpl20 at the cell surface (Fenouillet et al., 1993) .
That mutations of Env can affect its intracellular routing has been previously reported or suggested (Dash et al., 1994; Doms et al., 1993; Guo et al., 1990; Haffar et aL, 1990; Jowett & Jones, 1993; Willey et al., 1991) : for example, mutation of Leu-266 of gpl20 to Asp led to impaired cleavage and export from the ER (Willey et al., 1991) . Lack of processing in the absence of gp41 glycosylation therefore may be the result of the failure of the majority of gpl60 to progress to the compartment where cleavage occurs rather than any direct role of glycans in the cleavage process. This hypothesis is supported by our observation that mutant gpl60 overexpressed in insect cells co-expressing furin was cleaved in the same way as the wild-type molecule, although both the glycosylation and proteolytic machineries differ between mammalian and insect cells.
The exact reason why VV0 gp 160 processing is arrested at the ER/Golgi stage of the secretion pathway remains unknown. Recent mapping of Golgi retention signals has suggested that the transmembrane segment of Golgiresident proteins is involved in their retention in this compartment (Doms et al., 1993; Hurtley, 1992; Rose & Doms, 1988) . One possibility therefore is that glycosylation of the gp41 domain affects the conformation of the transmembrane domain of gpl60 and so prevents its normal transport. Interestingly, deletion of sequences near the transmembrane domain has been reported to alter the glycosylation of gp41 and the transport of Env (Haffar et al., 1990; Jowett & Jones, 1993) .
